Home
About Us
About the Bing Center
Directions / Find Us
Staff
Amanda Kofides, BS
Zachary Hunter, Ph.D
Steven Treon, MD, Ph.D
Phil Brodsky, BS
Nick Tsakmaklis, BA
Kirsten Meid, BA, MPH
Jorge Castillo, MD
Christopher Patterson, MS, BASc
Shayna Sarosiek, MD
Margaret Kobs DNP, FNP-BC
Hannah Chory, FNP-BC
Nina Budano, CRC II
Julia Nguyen, CRC
Alexandra Eurell, RC II
Alberto Guijosa Ramirez, MD
Maria Luisa Guerrera, MD
Tarek Mouhieddine, MD
Camille V. Edwards, MBBS
About WM
WM Overview
About WM
How We Diagnose WM
How We Treat WM
Patients
WM Clinic
Clinical Trials
News
Bing Center News
Newsletter Archive
Spotlight
Resources
Related Web Links
Media Gallery
Donate
Learn More
YouTube
Pubs
Contact
Pub-2012
Articles
Title
A multicenter phase II study of single-agent enzastaurin in previously treated Waldenstrom macroglobulinemia.
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma.
Challenges with serum protein electrophoresis in assessing progression and clinical response in patients with Waldenström macroglobulinemia.
Comparative response assessment by serum immunoglobulin M M-protein and total serum immunoglobulin M after treatment of patients with Waldenström macroglobulinemia.
Familial Disease Predisposition Impacts Treatment Outcome in Patients With Waldenström Macroglobulinemia
Family history of non-hematologic cancers among Waldenstrom macroglobulinemia patients: A preliminary study
Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia
microRNA aberrations in Waldenström macroglobulinemia.
Molecular and Cellular Effects of NEDD8-Activating Enzyme Inhibition in Myeloma.
Multiple myeloma, version 1.2013.
MYD88 L265P Somatic Mutation in Waldenström’s Macroglobulinemia
Response assessment in Waldenström macroglobulinaemia:Update from the 6th International Workshop on WM
Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013
